CHARM Therapeutics

company

About

CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$50M
Industries
Artificial Intelligence,Biotechnology
Founded date
Jan 1, 2021
Number Of Employee
1 - 10
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$50M
CHARM Therapeutics has raised a total of $50M in funding over 2 rounds. Their latest funding was raised on Jun 9, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 9, 2022 Series A $50M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
CHARM Therapeutics is funded by 1 investors. General Catalyst are the most recent investors.
Investor Name Lead Investor Funding Round
General Catalyst Series A